Skip to main content
$2.56 $0.13 (5.4%)

03:59 PM EDT on 09/20/23

AIKIDO PHARMA INC (NASDAQ:AIKI)

CAPS Rating: 1 out of 5

The Company operates via two principal segments, BioSpherix and InfoSpherix. BioSpherix develops proprietary products for commercial applications. InfoSpherix provides contact center information and reservation services for government and industry.

Current Price $2.56 Mkt Cap $13.7M
Open $2.49 P/E Ratio -0.50
Prev. Close $2.56 Div. (Yield) $0.00 (0.0%)
Daily Range $2.43 - $2.90 Volume 73,008
52-Wk Range $2.06 - $7.27 Avg. Daily Vol. 11,742

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

21 Outperform
27 Underperform
 

All-Star Players

2 Outperform
19 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:AIKI Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

cutchemist42 (64.64)
Submitted February 14, 2021

Mushrooms play.

SmartAce (99.98)
Submitted May 15, 2023

It's my job as a dad to walk through the house and say "it's cooling down tonight, good sleeping weather" and get absolutely no response from any family member.

Fools bullish on NASDAQ:AIKI are also bullish on:

Fools bearish on NASDAQ:AIKI are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about AIKI.

Recs

1
Member Avatar SmartAce (99.98) Submitted: 5/15/2023 12:58:12 PM : Underperform Start Price: $3.60 NASDAQ:AIKI Score: +35.25

It's my job as a dad to walk through the house and say "it's cooling down tonight, good sleeping weather" and get absolutely no response from any family member.

Recs

1
Member Avatar cutchemist42 (64.64) Submitted: 2/14/2021 11:55:53 AM : Outperform Start Price: $4.61 NASDAQ:AIKI Score: -51.95

Mushrooms play.

Recs

3
Member Avatar jed71 (88.53) Submitted: 5/10/2016 12:11:16 PM : Underperform Start Price: $1.89 NASDAQ:AIKI Score: +75.64

Yet another patent firm I don’t think very highly of. I know others have hit this one several times, but it looks to me like it needs another whacking. This one has a tendency of being super-volatile so be careful if you are joining me. I didn’t really pay a whole lot of attention to the chart, frankly because I think this is a close to worthless stub as I am able to find in the marketplace.

A bit about the firm:

“We are an intellectual property company that owns patented and unpatented intellectual property. Spherix Incorporated was formed in 1967 as a scientific research company and for much of our history pursued drug development, including through Phase III clinical studies, which were largely discontinued in 2012. In 2012 and 2013, we shifted our focus to being a firm that owns, develops, acquires and monetizes intellectual property assets. Through our acquisitions of 108 patents and patent applications from Rockstar Consortium US, LP ("Rockstar") and acquisition of several hundred patents issued to Harris Corporation as a result of our acquisition of North South Holdings, Inc. ("North South"), we have expanded our activities in wireless communications and telecommunication sectors including antenna technology, Wi-Fi, base station functionality and cellular.”

They’ve been around for a really long time (1967)!!! It looks like they’ve tried several different business plans, and from what I am seeing in their history, they haven’t been very successful in any of them. They have a long historical introduction in the recent 10-K if you want to see more about their travails over the past several years.

It’s obvious on the chart that they have reverse split multiple times in their history. If you go back to May of 2007, the share price after reverse splits is listed at nearly $11,000!!!!! They have about $3.5MM in cash and their free cash burn rate is about $5MM per year. So they have enough for about 9 months, but it’s obvious they are getting close to needing another reverse split and reissue of more shares. This is very, very, very easy points over the long term.

Great going concern statement that EVERY investor should read (and understand):

“We expect that as our business continues to grow we will need additional working capital. If adequate additional debt and/or equity financing is not available on reasonable terms or at all, we may not be able to continue to expand our business or pay our outstanding obligations, and we will have to modify our business plans accordingly. These factors would have a material and adverse effect on our future operating results and our financial condition. If we reach a point where we are unable to raise needed additional funds to continue as a going concern, we will be forced to cease our activities and dissolve the Company. In such an event, we will need to satisfy various creditors and other claimants, severance, lease termination and other dissolution-related obligations and we may not have sufficient funds to pay to our stockholders.”

Leaderboard

Find the members with the highest scoring picks in AIKI.

Score Leader

SmartAce

SmartAce (99.98) Score: +202.32

The Score Leader is the player with the highest score across all their picks in AIKI.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
DigDeepAnalytics 97.21 12/23/2014 Underperform 5Y $21.09 -87.86% +110.71% +198.57 0 Comment
whatisthepoint 94.31 5/24/2016 Underperform 5Y $3.30 -22.42% +110.70% +133.12 0 Comment
NobleOrSomeBull 99.76 7/7/2016 Underperform 5Y $2.17 +17.97% +109.19% +91.22 0 Comment
TinyCapsWatch 99.83 7/18/2016 Underperform 5Y $2.16 +18.51% +102.63% +84.12 0 Comment
tsperbeck 97.28 8/1/2016 Underperform 5Y $2.16 +18.52% +102.23% +83.71 0 Comment
jed71 88.53 5/10/2016 Underperform 5Y $1.89 +35.45% +111.09% +75.64 3 Comments
TheGreatSatan 99.97 7/25/2022 Underperform 5Y $6.27 -59.17% +10.84% +70.01 0 Comment
Zencyclone 32.26 8/9/2016 Underperform 5Y $1.70 +50.60% +100.68% +50.08 0 Comment
nonoise 88.57 11/22/2022 Underperform 5Y $4.04 -36.63% +10.59% +47.23 0 Comment
JoeySolitro3 99.46 7/23/2019 Underperform 5Y $2.35 +8.94% +46.87% +37.94 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for AIKI.